ameera-1 updates: amcenestrant plus palbociclib for patients with er /her2– advanced breast cancer
Published 2 years ago • 224 plays • Length 4:40Download video MP4
Download video MP3
Similar videos
-
1:25
ameera-5: amcenestrant palbociclib for previously untreated er /her2- advanced breast cancer
-
2:46
ameera-3: amcenestrant does not improve pfs in er /her2- breast cancer
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
0:52
patient eligibility in the ameera-6 trial of amcenestrant
-
1:51
ameera-3: serd for er her2- breast cancer
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
2:43
about advanced breast cancer treatment ibrance (palbociclib)
-
2:46
preliminary data on op-1250 palbociclib in advanced/metastatic er /her- breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
1:49
palbociclib combo therapies for advanced breast cancer
-
2:35
ameera-6: amcenestrant, a novel serd, in hr breast cancer
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
0:55
fulvestrant plus palbociclib in breast cancer
-
3:46
harmonia clinical trial
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
6:38
palbociclib shows improved pfs but not improved os for er her2- mbc patients
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
1:05
dr. verma on palbociclib plus fulvestrant for hr /her2- breast cancer